Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does FOSCARNET Cause Intentional product use issue? 41 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 41 reports of Intentional product use issue have been filed in association with FOSCARNET (Foscarnet Sodium). This represents 2.0% of all adverse event reports for FOSCARNET.

41
Reports of Intentional product use issue with FOSCARNET
2.0%
of all FOSCARNET reports
11
Deaths
9
Hospitalizations

How Dangerous Is Intentional product use issue From FOSCARNET?

Of the 41 reports, 11 (26.8%) resulted in death, 9 (22.0%) required hospitalization, and 3 (7.3%) were considered life-threatening.

Is Intentional product use issue Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for FOSCARNET. However, 41 reports have been filed with the FAERS database.

What Other Side Effects Does FOSCARNET Cause?

Off label use (610) Drug ineffective (368) Drug resistance (309) Acute kidney injury (246) Cytomegalovirus infection (200) Nephropathy toxic (198) Pathogen resistance (190) Renal impairment (184) Pancytopenia (170) Cytomegalovirus infection reactivation (167)

What Other Drugs Cause Intentional product use issue?

INFLIXIMAB (11,028) RITUXIMAB (9,602) INFLIXIMAB-DYYB (7,549) TOCILIZUMAB (5,078) METHOTREXATE (4,087) PREDNISONE (3,961) ABATACEPT (3,693) ADALIMUMAB (3,557) NIVOLUMAB (3,297) LEFLUNOMIDE (3,280)

Which FOSCARNET Alternatives Have Lower Intentional product use issue Risk?

FOSCARNET vs FOSFOMYCIN FOSCARNET vs FOSFOMYCIN TROMETHAMINE FOSCARNET vs FOSINOPRIL FOSCARNET vs FOSPHENYTOIN FOSCARNET vs FOSTAMATINIB

Related Pages

FOSCARNET Full Profile All Intentional product use issue Reports All Drugs Causing Intentional product use issue FOSCARNET Demographics